Dr. Paul Kempen gives view on negative effects of MOC


The “business of medicine summit” in October 2013 in Philadelphia will bring discussion on the matters of Maintenance of Certification, and possibly of licensure (MOL from the Federation of State Medical Boards). I have been personally and intensely involved in the battle of private physicians to expose the fallacy that this improves patient care in Ohio and nationally. An open discussion including open debate on this matter requires at least ONE opposing view presentation at such a meeting and the agenda does not include this important component.

I would be honored to attend, present and actively debate in open forum with any of the ABMS/ABIM leaders, who continue to press this MOC program as “optional”, although the ABMS has actively lobbied congress to pass discriminatory legislation, which will effectively result in mandatory MOC participation to maintain hospital, employee, Medicare and multiple private health insurance participation. With over $336 Million in documented revenues (cumulative IRS 990 documents) from MOC in 2011, the ABMS is an industry monopoly utilizing regulatory capture to transform Board certification from a singular training outcome evaluation documenting attainment of consultant status, into an entry level document allowing participation in their corporate brand of “certification for profit”, repeatedly documented as unwanted by physicians and without a shred of outcome based science to validate any improvement in anything except ABMS corporate income. Alone the simple fact that the ABMS programs are only relevant in the USA and excellence in healthcare is widely available for less throughout Europe, attests to the fallacy of this monopolistic brand of purchased credentials-which is effectively mere “medical guilds” for those who chose to join and to promote exclusion of those how have not joined- as 1/4 of all practicing US physicians have never become board certified! I hope Medical Economics will support an open debate on these important matters in this Medical Economics sponsored meeting.


Paul M Kempen, MD, PhD